Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aurinia Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AUPH
Nasdaq
8731
https://www.auriniapharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aurinia Pharmaceuticals Inc
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Apr 16th, 2024 2:48 pm
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
- Apr 15th, 2024 10:00 am
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
- Apr 9th, 2024 10:00 am
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?
- Apr 7th, 2024 2:47 pm
11 Oversold Biotech Stocks To Buy Right Now
- Mar 17th, 2024 9:20 pm
We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn
- Mar 8th, 2024 6:52 pm
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program
- Feb 29th, 2024 1:30 pm
Aurinia to Participate in Upcoming Investor Healthcare Conferences
- Feb 27th, 2024 1:30 pm
Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
- Feb 17th, 2024 12:35 pm
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 2:22 pm
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
- Feb 15th, 2024 12:25 pm
Aurinia Pharmaceuticals Inc (AUPH) Announces Year-End Financial Results and Strategic Initiatives
- Feb 15th, 2024 11:49 am
UPDATE 2-Aurinia Pharma fails to sell itself; to stop trials, cut jobs, buy back shares
- Feb 15th, 2024 11:19 am
Aurinia to cut research after sale process fails to find a buyer
- Feb 15th, 2024 11:10 am
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
- Feb 15th, 2024 11:00 am
Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Feb 13th, 2024 3:00 pm
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
- Feb 8th, 2024 3:00 pm
Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024
- Feb 5th, 2024 1:30 pm
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results
- Jan 5th, 2024 11:00 am
Painful week for retail investors invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) after 5.9% drop, institutions also suffered losses
- Jan 3rd, 2024 2:21 pm
Scroll